Panther Fusion GBS Assay

FDA 510(k) K181156 · Diagenode

Substantially Equivalent

510(k) numberK181156

Submission

Device name
Panther Fusion GBS Assay
Applicant
Diagenode
Seraing, BE
Received
May 1, 2018
Decision date
July 27, 2018
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
NJR – Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test
Device class
Class I (low risk)
Regulation
21 CFR 866.3740
Specialty
Microbiology

A nucleic acid amplification assay system (including probes, other reagents, and instrumentation) is an aid in the identification of group b streptococci from pre-partum and intra-partum women to establish colonization status.

Other 510(k)s with product code NJR

510(k)DeviceApplicantDecision
K222638Xpert® Xpress GBS, GeneXpert® Dx System, GeneXpert® Infinity SystemsNJR · Traditional Cepheid09/27/2023SE
K203429Xpert GBS LB XC, GeneXpert Dx System, GeneXpert Infinity SystemNJR · Traditional Cepheid05/09/2022SE
K182467Simplexa GBS Direct, Simplexa GBS Positive Control PackNJR · Traditional Diasorin Molecular, LLC11/07/2018SE
K173725NeuMoDx GBS AssayNJR · Traditional Neumodx Molecular, Inc.06/26/2018SE
K173250Solana GBS AssayNJR · Traditional Quidel Corporation12/21/2017SE
K170557GenePOC GBS LBNJR · Traditional Genepoc, Inc.05/25/2017SE
K162772ARIES GBS AssayNJR · Traditional Luminex Corporation12/23/2016SE
K143312Portrait GBS AssayNJR · Traditional Great Basin Corporation04/21/2015SE
K133503Amplivue GBS AssayNJR · Traditional Quidel Corporation12/20/2013SE
K121539Xpert GBS LB Genexpert DX Systems (Gx-I, Gx-Iv) Genexpert DX Systems (Gx-Xvi) Genexpert…NJR · Traditional Cepheid11/02/2012SE

Questions and answers

When was Panther Fusion GBS Assay cleared by the FDA?

Panther Fusion GBS Assay (K181156) received a 510(k) decision of Substantially Equivalent on July 27, 2018, 87 days after the submission was received.

What is the product code of K181156?

The FDA product code is NJR – Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test, a Class I (low risk) device regulated under 21 CFR 866.3740.